Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 94

Results For "Pharma"

3866 News Found

IOL Chemicals and Pharmaceuticals Q4 FY2022 PAT drops to Rs. 27.75 Cr
News | June 08, 2022

IOL Chemicals and Pharmaceuticals Q4 FY2022 PAT drops to Rs. 27.75 Cr

The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022


Future Packaging to redefine India Pharm industry growth: InnoPack Pharma
Packaging | June 07, 2022

Future Packaging to redefine India Pharm industry growth: InnoPack Pharma

The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.


NewAmsterdam Pharma shares new data from Phase 2b ROSE Study
News | June 07, 2022

NewAmsterdam Pharma shares new data from Phase 2b ROSE Study

82.5% of patients treated at 10mg dose of obicetrapib achieved LDL-c target of <70 mg/dL, compared to 20% of patients treated with placebo


MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib
News | June 07, 2022

MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib

he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients


Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr
News | June 06, 2022

Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr

Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore


ANI Pharmaceuticals consolidates operation post Novitium acquisition
News | June 06, 2022

ANI Pharmaceuticals consolidates operation post Novitium acquisition

Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023


Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
News | June 04, 2022

Indian pharma market to grow at a CAGR of 12.3% to US$130 bn

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030


Innate Pharma announces IPH5201 phase 2 study in lung cancer
News | June 04, 2022

Innate Pharma announces IPH5201 phase 2 study in lung cancer

Innate to receive $5M milestone payment from AstraZeneca


David Kendall named Zealand Pharma CMO
People | June 03, 2022

David Kendall named Zealand Pharma CMO

Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy


Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing
People | June 03, 2022

Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing

Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead